Corporate Partners

Chiesi is an international, research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly toward both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the U.S., and France, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi has been the world’s largest biopharmaceutical group to be certified as a B Corp, meaning that its sustainability efforts are measured and assessed by the most rigorous global standards. The company aims to become net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma, Italy, operates in 30 countries, and employs more than 6,000 people. The Group’s research and development center in Parma works alongside six other major R&D hubs in France, the U.S., Canada, China, the U.K., and Sweden.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists, and the nutrition community in an interactive way. In addition to being a major publisher of nutritional papers and journals, NNI organizes and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals, including doctors, nurses, midwives, and dietitians.

By sharing neutral, science-based information and education with healthcare professionals, the Institute fosters “Science for Better Nutrition” to help enhance the quality of life for people around the world.

Prolacta Bioscience® Inc. is a privately held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk–based nutritional products that are transforming the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide range of diseases, including applications for infants undergoing surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for screening and testing donor milk. Prolacta is a global company headquartered in Duarte, California.

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.

Inspired by patients, we take health personally – because health is personal.

We innovate with purpose to lead where medicine is going.

GE HealthCare is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions, dedicated to providing integrated solutions, services, and data analytics to make clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing connected and compassionate care while simplifying the patient journey across the care pathway. Together, we’re creating a world where healthcare has no limits.

Chiesi is an international, research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly toward both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the U.S., and France, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi has been the world’s largest biopharmaceutical group to be certified as a B Corp, meaning that its sustainability efforts are measured and assessed by the most rigorous global standards. The company aims to become net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma, Italy, operates in 30 countries, and employs more than 6,000 people. The Group’s research and development center in Parma works alongside six other major R&D hubs in France, the U.S., Canada, China, the U.K., and Sweden.

As professional congress organizers, MCA Events has been helping scientific organizations and societies plan the perfect congress or event since 1999. With their multi-faceted approach, MCA consults, guides, and supports clients throughout the entire process. MCA is a full-service event planning agency that manages every aspect in a time-efficient manner, ensuring all congresses and events are strategically planned, effectively organized, and aligned with the client’s goals. The agency is accustomed to working wherever clients choose to hold their events: Europe, North and South America, and recently, Asia. MCA experts leverage their in-depth knowledge and strong industry relationships to ensure every event is a success.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists, and the nutrition community in an interactive way. In addition to being a major publisher of nutritional papers and journals, NNI organizes and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals, including doctors, nurses, midwives, and dietitians.

By sharing neutral, science-based information and education with healthcare professionals, the Institute fosters “Science for Better Nutrition” to help enhance the quality of life for people around the world.

Sanofi is an innovative global healthcare company driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across approximately 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people worldwide, while putting sustainability and social responsibility at the center of our goals.

Sera Prognostics® aims to be a global leader in high-value women’s health diagnostics, delivering pivotal information to physicians to improve the health of pregnant women and newborns.

SIMCharacters develops pediatric simulators to improve medical care for critically ill children. Founder Jens Schwindt, a neonatologist, has learned that a highly professional interdisciplinary team is essential for effective medical care. SIMCharacters’ High Emotion Preterm Simulator, Paul, enables medical teams to train for critical neonatal emergencies in highly realistic conditions.